Ian F. Smith, Director at ACORDA THERAPEUTICS INC (ACOR), sold 25,000 shares at $31.42 ($786K) on 2018-06-15, disclosed to the SEC on 2018-06-19.
Scheduled sale ($786k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |
| ACOR | SELL | 2018-05-04 | $237K | — | Filing → |